Lemtrada May Also Cause ANCA Vasculitis

Lemtrada Stroke Lawsuit News

It seems as if every month, a new and deadly disease is being blamed on the multiple sclerosis medication

Monday, April 27, 2020 - Relapse-remitting multiple sclerosis sufferers can now add life-threatening ANCA Vasculitis to the already long list of deadly medical complications that are caused by taking the drug Lemtada (Alemtuzumab). ANCA stands for Anti-neutrophil cytoplasmic autoantibody (ANCA) vasculitis and is an autoimmune disease that causes blood vessels to swell, according to ANCA Vasculitis News (AVN). The publication reports that a 29-year old male developed Anca Vasculitis around one year after receiving Lemtrada infusions. According to AVN, "We report the case of a 29-year-old man with RRMS who developed fever, auricular chondritis, cutaneous vasculitis, and life-threatening diffuse alveolar hemorrhage, 12 months after alemtuzumab. Antibodies to myeloperoxidase appeared 9 months after alemtuzumab and were extremely high at the time of vasculitis... Thus, alemtuzumab may induce life-threatening vasculitis in patients treated for RRMS." The patient developed "inflammation in his ear cartilage and moderate fever, both of which failed to respond to antibiotics, along with bilateral pink eye, and signs of cutaneous bleeding in the legs," according to AVN. The patient also developed Graves Disease, an over-active thyroid condition. Other adverse Lemtrada symptoms that the patient suffered after a year included "a return of the symptoms in the ears, eyes, and legs, accompanied by shortness of breath and coughing up blood. Additional exams found pulmonary bleeding without infections, confirmed that the lesions in the legs were caused by vasculitis."

Lemtrada has the adverse side effect of causing one's immune system to attack the body's other organs. ANCA News describes "autoimmune problems arising from Lemtrada treatment (such as) thyroid diseases, in which the thyroid gland produces too much or too little hormones, kidney damage, and immune thrombocytopenic purpura (caused by an immune attack against platelets)." Lemtrada has proven to be highly effective in treating the symptoms of Relapse Remitting Multiple Sclerosis but is prescribed as the last resort when two or more alternative therapies have been attempted and failed.

RRMS patients have suffered strokes and heart attacks up to 48-72 hours after a Lemtrada infusion. Lemtrada's deadly side effects have been to destroy the inner lining of the arteries leading to the brain, lungs, and heart causing blood clots to develop. When a blood clot breaks free it can become lodged in a smaller blood vessel and cause a blockage and instant stroke or heart attack. If you or a loved one suffered from life-threatening ANCA Vasculitis, arterial dissection or stroke after taking Lemtrada, you should contact a Lemtrada attorney to see if you are eligible to file a claim against, Sanofi Genzyme, the maker of Lemtrada. Lemtrada lawsuits allow victims to seek compensation for their pain and suffering, as well as monetary compensation for medical expenses and lost income.

Lemtrada patients and their physicians must sign a lengthy questionnaire demonstrating they both understand the potential risks of taking the drug. Relapse remitting multiple sclerosis can, in some instances be controlled by taking Lemtada (Alemtuzumab) by reducing the frequency and duration of the disease's symptoms.

More Recent Lemtrada Stroke Lawsuit News:

No-Cost, No-Obligation Lemtrada Lawsuit Case Review If You or a Loved One Suffered from Lemtrada Stroke Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.